A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice

References

• Andersen ME, Clewell HJ III, Gargas ML, Smith FA, Reitz RH. 1987. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol Appl Pharmacol 87:185–205
   PubMed Web of Science ®Google Scholar
• Arvizo RR, Bhattacharyya S, Kudgus RA, Giri K, Bhattacharya R, Mukherjee P. 2012. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev 41:2943–70
   PubMed Web of Science ®Google Scholar
• Bachler G, von Goetz N, Hungerbuhler K. 2013. A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles. Int J Nanomed 8:3365–82
   PubMed Web of Science ®Google Scholar
• Bachler G, von Goetz N, Hungerbuhler K. 2014. Using physiologically based pharmacokinetic (PBPK) modeling for dietary risk assessment of titanium dioxide (TiO2) nanoparticles. Nanotoxicology 1–8 . [Epub ahead of print]. doi:10.3109/17435390.2014.940404
   Web of Science ®Google Scholar
• Balasubramanian SK, Jittiwat J, Manikandan J, Ong CN, Yu LE, Ong WY. 2010. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 31:2034–42
   PubMed Web of Science ®Google Scholar
• Bazile D, Prud'homme C, Bassoullet MT, Marlard M, Spenlehauer G, Veillard M. 1995. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 84:493–8
   PubMed Web of Science ®Google Scholar
• Braet F, Wisse E. 2002. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol 1:1
   PubMedGoogle Scholar
• Buur JL, Baynes RE, Riviere JE. 2008. Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model. Regul Toxicol Pharmacol 51:324–31
   PubMed Web of Science ®Google Scholar
• Canton I, Battaglia G. 2012. Endocytosis at the nanoscale. Chem Soc Rev 41:2718–39
   PubMed Web of Science ®Google Scholar
• Cesta MF. 2006. Normal structure, function, and histology of the spleen. Toxicol Pathol 34:455–65
   PubMed Web of Science ®Google Scholar
• Cho WS, Cho M, Jeong J, Choi M, Cho HY, Han BS, et al. 2009a. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236:16–24
   PubMed Web of Science ®Google Scholar
• Cho WS, Cho M, Jeong J, Choi M, Han BS, Shin HS, et al. 2010. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 245:116–23
   PubMed Web of Science ®Google Scholar
• Cho WS, Kim S, Han BS, Son WC, Jeong J. 2009b. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. Toxicol Lett 191:96–102
   PubMed Web of Science ®Google Scholar
• Chou LY, Chan WC. 2012. Fluorescence-tagged gold nanoparticles for rapidly characterizing the size-dependent biodistribution in tumor models. Adv Healthcare Mater 1:714–21
   Web of Science ®Google Scholar
• Dykman LA, Khlebtsov NG. 2014. Uptake of engineered gold nanoparticles into mammalian cells. Chem Rev 114:1258–88
   PubMed Web of Science ®Google Scholar
• Fisher JW, Twaddle NC, Vanlandingham M, Doerge DR. 2011. Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans. Toxicol Appl Pharmacol 257:122–36
   PubMed Web of Science ®Google Scholar
• Geffroy B, Ladhar C, Cambier S, Treguer-Delapierre M, Brethes D, Bourdineaud JP. 2012. Impact of dietary gold nanoparticles in zebrafish at very low contamination pressure: the role of size, concentration and exposure time. Nanotoxicology 6:144–60
   PubMed Web of Science ®Google Scholar
• Gordon S, Taylor PR. 2005. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–64
   PubMed Web of Science ®Google Scholar
• Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, et al. 2000. ‘Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 18:301–13
   PubMed Web of Science ®Google Scholar
• Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schaffler M, et al. 2011. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 77:407–16
   PubMed Web of Science ®Google Scholar
• Jones HM, Mayawala K, Poulin P. 2013. Dose selection based on physiologically based pharmacokinetic (PBPK) approaches. AAPS J 15:377–87
   PubMed Web of Science ®Google Scholar
• Khlebtsov N, Dykman L. 2011. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 40:1647–71
   PubMed Web of Science ®Google Scholar
• Landsiedel R, Fabian E, Ma-Hock L, van Ravenzwaay B, Wohlleben W, Wiench K, et al. 2012. Toxico-/biokinetics of nanomaterials. Arch Toxicol 86:1021–60
   PubMed Web of Science ®Google Scholar
• Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, et al. 2010. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31:8350–61
   PubMed Web of Science ®Google Scholar
• Leavens TL, Tell LA, Kissell LW, Smith GW, Smith DJ, Wagner SA, et al. 2014. Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus). Food Addit Contam Part A 31:1506–21
   PubMed Web of Science ®Google Scholar
• Lee HA, Leavens TL, Mason SE, Monteiro-Riviere NA, Riviere JE. 2009. Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model. Nano Lett 9:794–9
   PubMed Web of Science ®Google Scholar
• Li D, Johanson G, Emond C, Carlander U, Philbert M, Jolliet O. 2014. Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats. Nanotoxicology 8:128–37
   PubMed Web of Science ®Google Scholar
• Li M, Al-Jamal KT, Kostarelos K, Reineke J. 2010. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano 4:6303–17
   PubMed Web of Science ®Google Scholar
• Li M, Panagi Z, Avgoustakis K, Reineke J. 2012. Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content. Int J Nanomed 7:1345–56
   PubMed Web of Science ®Google Scholar
• Lin P, Chen JW, Chang LW, Wu JP, Redding L, Chang H, et al. 2008. Computational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in mice. Environ Sci Technol 42:6264–70
   PubMed Web of Science ®Google Scholar
• Lin Z, Fisher JW, Wang R, Ross MK, Filipov NM. 2013. Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling. Toxicol Appl Pharmacol 273:140–58
   PubMed Web of Science ®Google Scholar
• Lin Z, Li M, Gehring R, Riviere JE. 2015. Development and application of a multi-route physiologically based pharmacokinetic model for oxytetracycline in dogs and humans. J Pharm Sci 104:233–43
   PubMed Web of Science ®Google Scholar
• Lin Z, Monteiro-Riviere NA, Riviere JE. 2015. Pharmacokinetics of metallic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7:189–217
   Google Scholar
• Liu X, Huang N, Wang H, Li H, Jin Q, Ji J. 2013. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles. Biomaterials 34:8370–81
   PubMed Web of Science ®Google Scholar
• Mager DE, Mody V, Xu C, Forrest A, Lesniak WG, Nigavekar SS, et al. 2012. Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo disposition. Pharm Res 29:2534–42
   PubMed Web of Science ®Google Scholar
• Manson J, Kumar D, Meenan BJ, Dixon D. 2011. Polyethylene glycol functionalized gold nanoparticles: the influence of capping density on stability in various media. Gold Bull 44:99–105
   Web of Science ®Google Scholar
• Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543–57
   PubMed Web of Science ®Google Scholar
• Pery AR, Brochot C, Hoet PH, Nemmar A, Bois FY. 2009. Development of a physiologically based kinetic model for 99m-technetium-labelled carbon nanoparticles inhaled by humans. Inhal Toxicol 21:1099–107
   PubMed Web of Science ®Google Scholar
• Praetorius A, Tufenkji N, Goss K-U, Scheringer M, von der Kammer F, Elimelech M. 2014. The road to nowhere: equilibrium partition coefficients for nanoparticles. Environ Sci: Nano 1:317–23
   Web of Science ®Google Scholar
• Riviere JE. 2009. Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:26–34
   PubMed Web of Science ®Google Scholar
• Riviere JE. 2013. Of mice, men and nanoparticle biocoronas: are in vitro to in vivo correlations and interspecies extrapolations realistic? Nanomedicine (Lond) 8:1357–9
   PubMed Web of Science ®Google Scholar
• Sahneh FD, Scoglio CM, Monteiro-Riviere NA, Riviere JE. 2015. Predicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modeling. Nanomedicine (Lond) 10:25–33
   Google Scholar
• Teeguarden JG, Deisinger PJ, Poet TS, English JC, Faber WD, Barton HA, et al. 2005. Derivation of a human equivalent concentration for n-butanol using a physiologically based pharmacokinetic model for n-butyl acetate and metabolites n-butanol and n-butyric acid. Toxicol Sci 85:429–46
   PubMed Web of Science ®Google Scholar
• van Furth R, Cohn ZA, Hirsch JG, Humphrey JH, Spector WG, Langevoort HL. 1972. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ 46:845–52
   PubMed Web of Science ®Google Scholar
• WHO. 2010. International Programme on Chemical Safety Harmonization Project Document No. 9. Characterization and application of physiologically based pharmacokinetic models in risk assessment. Geneva, Switzerland: World Health Organization, 21–37
   Google Scholar
• Zhang G, Yang Z, Lu W, Zhang R, Huang Q, Tian M, et al. 2009. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 30:1928–36
   PubMed Web of Science ®Google Scholar
• Zhang LW, Baumer W, Monteiro-Riviere NA. 2011. Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells. Nanomedicine (Lond) 6:777–91
   PubMed Web of Science ®Google Scholar
• Zhang LW, Monteiro-Riviere NA. 2009. Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol Sci 110:138–55
   PubMed Web of Science ®Google Scholar